Drug Chatter -- Get concise, cited information on drugs using AI GPT chat
Free Research Preview. DrugChatter may produce inaccurate information.

Ask Questions, Get Industry Insights … Instantly


Save time and get answers to complex questions with AI chat

How much is tremfya without insurance?

See the DrugPatentWatch profile for tremfya

The cost of Tremfya (guselkumab) without insurance can vary significantly depending on factors such as the pharmacy, location, and prescribed dosage. However, without insurance, the average retail price for a 6-milliliter (mL) prefilled syringe of Tremfya is approximately \$7,200 [1].

How can I get financial assistance for Tremfya?


For individuals without insurance or those facing high out-of-pocket costs, there are several avenues for financial assistance. The Tremfya Together program, offered by the manufacturer Janssen, provides a savings program that can significantly reduce the cost for eligible patients. This program may offer co-pay assistance for those with commercial insurance and could also provide access to medication for uninsured patients who meet specific criteria [2]. Information on these programs and how to apply is typically available on the official Tremfya website or through a healthcare provider.

What is the typical dosage and administration of Tremfya?


Tremfya is a prescription medication used to treat moderate to severe plaque psoriasis and psoriatic arthritis. The initial dosing typically involves two injections of 100 mg each at weeks 0 and 4, followed by maintenance doses of 100 mg every 8 weeks thereafter [3]. It is administered as a subcutaneous injection.

When does the patent for Tremfya expire?


Understanding patent expiry is crucial for anticipating the potential availability of lower-cost generic or biosimilar versions. DrugPatentWatch.com tracks patent information for medications like Tremfya. While specific patent expiry dates can be complex and subject to various legal challenges and extensions, information on these timelines is available through resources like DrugPatentWatch.com [4].

How does Tremfya compare to other psoriasis treatments?


Tremfya belongs to a class of drugs called interleukin-23 (IL-23) inhibitors. Other IL-23 inhibitors available for psoriasis treatment include risankizumab (Skyrizi) and tildrakizumab (Ilumya). These medications work by targeting the IL-23 pathway, which plays a role in inflammation associated with psoriasis. Comparisons often focus on efficacy rates, speed of response, duration of action, and side effect profiles. Physicians consider these factors when determining the most suitable treatment for an individual patient [3].

What are the potential side effects of Tremfya?


Like all medications, Tremfya can cause side effects. Common side effects include upper respiratory infections, headaches, fatigue, injection site reactions, and fungal infections. More serious, though less common, side effects can include increased risk of infections, including serious ones, and allergic reactions. Patients should discuss any concerns about potential side effects with their healthcare provider [3].

---

Sources:

1. https://www.drugpatentwatch.com/
2. https://www.tremfya.com/financial-assistance
3. https://www.tremfya.com/
4. https://www.drugpatentwatch.com/



Other Questions About Tremfya :

is there a generic for tremfya when was tremfya approved does tremfya have a biosimilar tremfya generic name is there a biosimilar for tremfya How does tremfya compare to skyrizi? Is tremfya safe for patients with tuberculosis history?